430 related articles for article (PubMed ID: 38490647)
1. Advances in the understanding of the pathophysiology of schizophrenia and bipolar disorder through induced pluripotent stem cell models.
Perrottelli A; Marzocchi FF; Caporusso E; Giordano GM; Giuliani L; Melillo A; Pezzella P; Bucci P; Mucci A; Galderisi S
J Psychiatry Neurosci; 2024; 49(2):E109-E125. PubMed ID: 38490647
[TBL] [Abstract][Full Text] [Related]
2. Application of induced pluripotent stem cells to understand neurobiological basis of bipolar disorder and schizophrenia.
Liu YN; Lu SY; Yao J
Psychiatry Clin Neurosci; 2017 Sep; 71(9):579-599. PubMed ID: 28393474
[TBL] [Abstract][Full Text] [Related]
3. Disease signatures for schizophrenia and bipolar disorder using patient-derived induced pluripotent stem cells.
Watmuff B; Berkovitch SS; Huang JH; Iaconelli J; Toffel S; Karmacharya R
Mol Cell Neurosci; 2016 Jun; 73():96-103. PubMed ID: 26777134
[TBL] [Abstract][Full Text] [Related]
4. Using iPSC Models to Understand the Role of Estrogen in Neuron-Glia Interactions in Schizophrenia and Bipolar Disorder.
Reis de Assis D; Szabo A; Requena Osete J; Puppo F; O'Connell KS; A Akkouh I; Hughes T; Frei E; A Andreassen O; Djurovic S
Cells; 2021 Jan; 10(2):. PubMed ID: 33494281
[TBL] [Abstract][Full Text] [Related]
5. Modeling Psychiatric Disorder Biology with Stem Cells.
Das D; Feuer K; Wahbeh M; Avramopoulos D
Curr Psychiatry Rep; 2020 Apr; 22(5):24. PubMed ID: 32318888
[TBL] [Abstract][Full Text] [Related]
6. Stem cell-derived neurons in the development of targeted treatment for schizophrenia and bipolar disorder.
Watmuff B; Liu B; Karmacharya R
Pharmacogenomics; 2017 Apr; 18(5):471-479. PubMed ID: 28346060
[TBL] [Abstract][Full Text] [Related]
7. A dangerous method? The use of induced pluripotent stem cells as a model for schizophrenia.
Jacobs BM
Schizophr Res; 2015 Oct; 168(1-2):563-8. PubMed ID: 26194993
[TBL] [Abstract][Full Text] [Related]
8. Understanding neurodevelopmental disorders using human pluripotent stem cell-derived neurons.
Tamburini C; Li M
Brain Pathol; 2017 Jul; 27(4):508-517. PubMed ID: 28585386
[TBL] [Abstract][Full Text] [Related]
9. Generation and characterization of human-derived iPSC lines from two cousins with schizophrenia and bipolar disorder and their unaffected cousin.
Ni P; Zhou C; Meng Y; Xue R; Yang X; Li L; Zhao L; Wei J; Ni R; Wang Y; Ma X; Guo W; Wang Q; Li T
Stem Cell Res; 2022 Aug; 63():102832. PubMed ID: 35700633
[TBL] [Abstract][Full Text] [Related]
10. Dysregulation of Neurite Outgrowth and Cell Migration in Autism and Other Neurodevelopmental Disorders.
Prem S; Millonig JH; DiCicco-Bloom E
Adv Neurobiol; 2020; 25():109-153. PubMed ID: 32578146
[TBL] [Abstract][Full Text] [Related]
11.
Ishii T; Ishikawa M; Fujimori K; Maeda T; Kushima I; Arioka Y; Mori D; Nakatake Y; Yamagata B; Nio S; Kato TA; Yang N; Wernig M; Kanba S; Mimura M; Ozaki N; Okano H
eNeuro; 2019; 6(5):. PubMed ID: 31540999
[TBL] [Abstract][Full Text] [Related]
12. Characterization of bipolar disorder patient-specific induced pluripotent stem cells from a family reveals neurodevelopmental and mRNA expression abnormalities.
Madison JM; Zhou F; Nigam A; Hussain A; Barker DD; Nehme R; van der Ven K; Hsu J; Wolf P; Fleishman M; O'Dushlaine C; Rose S; Chambert K; Lau FH; Ahfeldt T; Rueckert EH; Sheridan SD; Fass DM; Nemesh J; Mullen TE; Daheron L; McCarroll S; Sklar P; Perlis RH; Haggarty SJ
Mol Psychiatry; 2015 Jun; 20(6):703-17. PubMed ID: 25733313
[TBL] [Abstract][Full Text] [Related]
13. The iPSC perspective on schizophrenia.
Räsänen N; Tiihonen J; Koskuvi M; Lehtonen Š; Koistinaho J
Trends Neurosci; 2022 Jan; 45(1):8-26. PubMed ID: 34876311
[TBL] [Abstract][Full Text] [Related]
14. Neurodevelopmental pathways in bipolar disorder.
Kloiber S; Rosenblat JD; Husain MI; Ortiz A; Berk M; Quevedo J; Vieta E; Maes M; Birmaher B; Soares JC; Carvalho AF
Neurosci Biobehav Rev; 2020 May; 112():213-226. PubMed ID: 32035092
[TBL] [Abstract][Full Text] [Related]
15. Neurodevelopmental origins of bipolar disorder: iPSC models.
O'Shea KS; McInnis MG
Mol Cell Neurosci; 2016 Jun; 73():63-83. PubMed ID: 26608002
[TBL] [Abstract][Full Text] [Related]
16. Stem cell models of schizophrenia, what have we learned and what is the potential?
Moslem M; Olive J; Falk A
Schizophr Res; 2019 Aug; 210():3-12. PubMed ID: 30587427
[TBL] [Abstract][Full Text] [Related]
17. Mitochondrial, cell cycle control and neuritogenesis alterations in an iPSC-based neurodevelopmental model for schizophrenia.
Zuccoli GS; Nascimento JM; Moraes-Vieira PM; Rehen SK; Martins-de-Souza D
Eur Arch Psychiatry Clin Neurosci; 2023 Dec; 273(8):1649-1664. PubMed ID: 37039888
[TBL] [Abstract][Full Text] [Related]
18. Pluripotent stem cells in neuropsychiatric disorders.
Soliman MA; Aboharb F; Zeltner N; Studer L
Mol Psychiatry; 2017 Sep; 22(9):1241-1249. PubMed ID: 28322279
[TBL] [Abstract][Full Text] [Related]
19. The application of human pluripotent stem cells to model the neuronal and glial components of neurodevelopmental disorders.
Lee KM; Hawi ZH; Parkington HC; Parish CL; Kumar PV; Polo JM; Bellgrove MA; Tong J
Mol Psychiatry; 2020 Feb; 25(2):368-378. PubMed ID: 31455859
[TBL] [Abstract][Full Text] [Related]
20. From the Psychiatrist's Couch to Induced Pluripotent Stem Cells: Bipolar Disease in a Dish.
Hoffmann A; Sportelli V; Ziller M; Spengler D
Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29517996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
